Noopept Protocol
Dosing & Research
Last Updated: September 4, 2026
Memory and learning research, Neuroprotection, BDNF/NGF signaling, Nootropic studies
Half-Life
~5 Minutes (active Metabolite Cycloprolylglycine Longer)
Administration
• Oral
• Intranasal
Frequency
1-3 times daily (morning and early afternoon preferred)
How It Works
- Memory and learning research
- Neuroprotection
- BDNF/NGF signaling
- Nootropic studies
Dosing Structure
Dose
10–20 mg
Frequency
1-3 times daily (morning and early afternoon preferred)
Notes
Break: 2-4 weeks between cycles to allow receptor recovery period.
Example Protocols
Dose: 10–20 mg
Frequency: 1-3 times daily (morning and early afternoon preferred)
Duration: 4-8 weeks
Off Period: Not listed
Find Research Grade Noopept
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Break: 2-4 weeks between cycles to allow receptor recovery period.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.